معرفی
Dr. Alexander Maass is a staff cardiologist at the Faculty of Medical Sciences, University of Groningen, specializing in cardiac devices and heart failure. He actively contributes to Cardiac Resynchronization Therapy (CRT) and Implantable Cardioverter-Defibrillator (ICD) research, with leadership roles in the BioWomen Study (Biotronik) and ADVISE III Study (ZonMW, CartTech). His clinical expertise includes implantable cardiac devices, CRT optimization, and shared decision-making in cardiology.
- Key Affiliations: Cardiovascular Centre (CVC), Netherlands Society of Cardiology (NVVC), EU Expert Panel, Boston Scientific consultancy.
His research spans CRT lead placement accuracy (ADVISE-CRT III), ICD efficacy in non-ischemic cardiomyopathy, and pain management post-S-ICD implantation. Recent studies explore sex-specific responses to CRT and device failure rates. He serves on editorial boards for Heart and PLoS ONE and contributes to clinical guidelines.
- Scientific Contributions:
- 2025: ESC CRT guidelines endorsement
- 2025: Doxorubicin cardiotoxicity prevention via dantrolene
- 2024: S-ICD pain analysis (PRAETORIAN-DFT)
- 2023: ICD efficacy prediction models